
Ixoglime GM 1 Tablet ER
Marketer
Unique Life Sciences (P) Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Ixoglime GM 1 Tablet ER
Glycemic control medication, Ixoglime GM 1 Extended-Release tablet, combines two anti-diabetic agents to manage type 2 diabetes in adults. This medication assists in regulating blood glucose. Administer Ixoglime GM 1 ER with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood glucose response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to successful diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your physician of any history of heart disease prior to commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Primary Ingredients of Ixoglime GM 1 Tablet ER
No text provided. Please provide the text you would like me to rephrase.
Uses of Ixoglime GM 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Ixoglime GM 1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Ixoglime GM 1 Tablet ER with a meal.
Common Side effects of Ixoglime GM 1 Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Ixoglime GM 1 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Ixoglime GM 1 Tablet ER with a meal.
How Ixoglime GM 1 Tablet ER works:
Ixoglime GM 1 Extended-Release tablet combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ixoglime GM 1 Tablet ER and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ixoglime GM 1 Tablet ER during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Ixoglime GM 1 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Ixoglime GM 1 Tablet ER with close medical supervision. A modified dosage may be necessary. Consult your physician. Ixoglime GM 1 Tablet ER is contraindicated in patients with severe renal insufficiency. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
For individuals with liver impairment, Ixoglime GM 1 Tablet ER requires careful administration. Dosage modification of Ixoglime GM 1 Tablet ER might be necessary. Physician consultation is advised. In patients exhibiting mild to moderate hepatic dysfunction, Ixoglime GM 1 Tablet ER is typically initiated at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Ixoglime GM 1 Tablet ER :
Should you forget to take your Ixoglime GM 1 Tablet ER, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ixoglime GM 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
